Form D · Other Health Care

Qool Therapeutics, Inc.

Menlo Park, CA · CIK 0001658096

Offering snapshot reported Jul 27, 2018 · SEC filing

Reported sold
$14M
Offering amount: $15.2M
Investors reported
76
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Nov 8, 2017
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$6.98M$14MFeb 23, 2017: $6,704,839.00Feb 23, 2017Jul 27, 2018: $13,959,750.00Jul 27, 2018

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$6,704,839 → $13,959,750
  • Reported investors65 → 76

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 27, 2018Amendment$13,959,750$7,254,911vs Feb 23, 201776SEC filing
Feb 23, 2017Initial$6,704,839No comparison65SEC filing
Nov 13, 2015Initial$250,000No comparison5SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-281229

Source: Form D, filed Jul 27, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Amir Belson Director, Executive
Todd Brinton Director
James Dennis Director
Ron Dieck Director
Beverly Huss Director, Executive
Fred Moll Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
1455 Adams Drive Suite 2014
Menlo Park, CA, 94025